“Dermatological toxicity due to targeted anticancer drugs: A new challenge in Oncology practice”, J Pak Assoc Dermatol, vol. 32, no. 3, pp. 557–566, Aug. 2022, doi: 10.66344/jpad.v32i3.1958.